Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinoma

The aim of this study was to assess the safety and efficacy of biweekly irinotecan plus leucovorin-modulated 5-fluorouracil i.v. bolus in metastatic colorectal carcinoma according to the age of patients. For this purpose, we have analysed 108 patients randomly allocated to receive irinotecan 200 mg ...

Descripción completa

Detalles Bibliográficos
Autores principales: Comella, P, Farris, A, Lorusso, V, Palmeri, S, Maiorino, L, Lucia, L De, Buzzi, F, Mancarella, S, Vita, F De, Gambardella, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376956/
https://www.ncbi.nlm.nih.gov/pubmed/12966414
http://dx.doi.org/10.1038/sj.bjc.6601214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376956/
https://www.ncbi.nlm.nih.gov/pubmed/12966414
http://dx.doi.org/10.1038/sj.bjc.6601214

Ejemplares similares